Louis Alvarez Email and Phone Number

Market Development of a new investigational product that is designed to be the first cholesterol-lowering medicine in the small interfering RNA (siRNA) class.Engage in scientifically accurate and unbiased discussions with the medical community to include published and emerging data.

Travel to Europe, Hawaii and throughout the United States.

Market Development in Rare Disease: Promote Disease Awareness with Key Opinion Leaders in Academic Institutions. Support Ad Board meetings and provide speaker training. Coordinate and help establish connections with Marketing Team and KOLs. Attended National Scientific Meetings to further scientific knowledge.Clinical Trials: Site Lead; place and support clinical trials.Managed Care: Rare Disease Presentations to Key Accounts.Sales Support: Didactic Presentations and Field support for community leaders ( handling of scientific questions, research questions and grant proposals).

Primary responsibility is to raise awareness about rare diseases (Lysosomal Acid Lipase Deficiency) and in the near future other pipeline programs with key specialists so that the disease is included in the differential diagnosis of patients with signs and symptoms that are considered highly suspicious for the disorder.(Synageva Was Purchased By Alexion In June 2015)

Health Science Consultant / Medical Science Liaison 2004 - 2014Created a reliable presence by engaging academically based Community Leaders and other academic Thought Leaders in scientific discussions aligned with approved scientific issues. Responsible for market development of diabetes pathophysiology and the launch of Januvia (new class of drugs in Diabetes arena).• Consistently demonstrated a collegial understanding of basic science, disease state, and in response to questions from Thought Leaders, therapeutic/product information. Built and further developed a trusting scientific based relationship with Thought Leaders. • Developed and implemented quality assignment management plans that were consistent with approved tools and supportive of the National Tactical Plan and the scientific issue process.• Utilized relevant and approved Health Science resources consistent with the assignment plan.• Executed speaker liaison role with assigned and contracted speakers consistent with Merck Medical Education guidelines and program objectives in line with the National Tactical Plans.• Developed and certified speakers based on content, audience needs and adult learning principles.• Demonstrated responsive interaction with program owners to ensure high quality Merck Medical Forums programming which was consistent with product labeling.• Attended National Scientific Meetings – American Heart Association, American College of Cardiology, American Diabetes Association, Arteriosclerosis, Thrombosis and Vascular Biology, Keystone Symposia for further education in order to keep current in the industry.• Member of Atherosclerosis Scientific Advisory Board – worked closely with marketing team to develop scientific platform for atherosclerosis products, identify and or develop resources; research papers, slide sets and medical education.